Sign Up to like & get
recommendations!
0
Published in 2019 at "Osteoporosis International"
DOI: 10.1007/s00198-019-04906-x
Abstract: Glucocorticoids remain widely used for many medical conditions, and fractures are the most serious common adverse event related to long-term glucocorticoid use. Glucocorticoid-induced osteoporosis (GIOP) develops in a time- and dose-dependent manner, but even at…
read more here.
Keywords:
risk;
giop;
fracture;
glucocorticoid induced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000033278
Abstract: Background: Glucocorticoid-induced osteoporosis (GIOP) is the most common secondary osteoporosis. Bushen Jiangu (BSJG), a classic traditional Chinese medicine (TCM) therapy, is widely used for treatment of GIOP. We conducted a meta-analysis to evaluate the effectiveness…
read more here.
Keywords:
bsjg therapy;
therapy;
analysis;
giop ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Stem Cells International"
DOI: 10.1155/2022/3249737
Abstract: Background Circular RNAs (circRNAs) contribute to the regulation of many diseases. However, little is known about the role of circRNAs in the development of glucocorticoid-induced osteoporosis (GIOP). The present study is aimed at systematically characterizing…
read more here.
Keywords:
glucocorticoid;
expression;
induced osteoporosis;
giop ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.920931
Abstract: Background Glucocorticoid-induced osteoporosis (GIOP) is a common form of secondary osteoporosis caused by the protracted or a large dosage of glucocorticoids (GCs). Total flavonoids of Drynariae rhizoma (TFDR) have been widely used in treating postmenopausal…
read more here.
Keywords:
pharmacology;
osteoporosis;
analysis;
giop ... See more keywords